Search the Newsreel

Cincinnati Financial Corp (CINF) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cincinnati Financial Corp (CINF), highlighting its current earnings forecast score of 7.00 and an average analyst price target of $174.50. Based on 10 analysts, the stock receives a "Hold" rating. Key financial metrics such as expected quarterly …

Innospec Inc (IOSP) Earnings Forecast: Future EPS & Revenue Growth Estimates

Innate Pharma plans phase 3 trial, names new medical officer By Investing.com

Innate Pharma SA (Euronext Paris: IPH; NASDAQ: IPHA) announced plans for a Phase 3 study of lacutamab for cutaneous T-cell lymphoma, contingent on a partnership with Sobi. The company also appointed Markus Jensen as its new Chief Medical Officer, effective September 1, 2026. The …

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study …

Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer

Strip Tinning secures £3m government grant for UK expansion By Investing.com

Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma

Innate Pharma has entered into a strategic partnership with Sobi to license lacutamab for T-cell lymphoma, aiming to accelerate its development and potential approval. Sobi will receive exclusive global commercialization rights, while Innate will conduct the TELLOMAK-3 Phase 3 study to support accelerated approval …

Fortune Brands Innovations, Inc. (NYSE:FBIN) Given Consensus Rating of "Hold" by Brokerages

Fortune Brands Innovations (NYSE:FBIN) has received a consensus "Hold" rating from fifteen brokerage firms, with an average 12-month price target of $55.33. The company recently reported adjusted EPS of $1.35, exceeding expectations, though revenue declined by 4.1% year-over-year. FBIN also declared a quarterly dividend …

Strip Tinning Holdings Secures £3 Million DRIVE35 Grant to Boost UK Manufacturing of Cell Contacting Systems

REG - Strip Tinning Hldgs - Award of DRIVE35 Grant

Innovate Corp (VATE) Stock Forecast & Analyst Ratings

This article provides an analyst rating and stock forecast for Innovate Corp (VATE). Analysts have given VATE a "Hold" rating with a target price of $3.50. The forecast suggests a potential upside of 113.41% from its current price.

Fortune Brands Innovations, Inc (FBIN) Stock forecasts

This Insider Has Just Sold Shares In GoFintech Quantum Innovation

Innovent Biologics and Daiichi Sankyo Enter Exclusive Agreement for VANFLYTA® Commercialization in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML SAN FRANCISCO and SUZHOU, China, Aug. 9, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (01801.HK) and Daiichi Sankyo (TSE: 4568), have entered into an exclusive agreement for the commercialization of Vanflyta® …

Could Pinnacle (ASX:PNI) Lead This Dividend Trio?

Finning International Q2 Earnings Call Highlights

Finning International (TSE:FTT) reported record second-quarter earnings, with revenue exceeding C$3 billion for the first time and adjusted by strong equipment deliveries, product support growth and a record backlog. President and CEO Kevin Parkes said the company generated record quarterly earnings per share of …

Nahar Spinning Mills Ltd is Rated Hold by MarketsMOJO

Columbus McKinnon delivers 66% return after Fair Value call

InvestingPro's Fair Value analysis identified Columbus McKinnon Corporation (NASDAQ:CMCO) as significantly undervalued in April 2025, leading to a 65.64% return for investors. The company's shares rose from $12.98 to $21.50 due to strong fundamental improvements, including a 54.6% surge in revenue and a doubling …

INNOVATE Q2 Earnings Call Highlights

Key Points Interested in INNOVATE Corp.? Here are five stocks we like better. INNOVATE delivered a sharp year-over-year improvement: Second-quarter revenue rose 74.2% to $421.6 million, net income reached $10.4 million versus a prior-year loss, and adjusted EBITDA increased to $46.3 million. Infrastructure drove …

Jefferies Sticks to Their Buy Rating for Innovex International (INVX)

Jefferies has reiterated a Buy rating on Innovex International (INVX) with a price target of $35.00. This aligns with the current analyst consensus of a Moderate Buy and an average price target of $34.50. The company reported strong Q2 results, with increased revenue and …

Nitin Spinners Publishes Q1 FY27 Investor Presentation Under SEBI Norms

Renaissance Technologies LLC Acquires 186,117 Shares of InnovAge Holding Corp. $INNV

Renaissance Technologies LLC increased its stake in InnovAge Holding Corp. (NASDAQ:INNV) by 100.8% in the first quarter, purchasing an additional 186,117 shares to hold a total of 370,817 shares valued at approximately $2.97 million. Other institutional investors like Bank of America and Goldman Sachs …

Bank of New York Mellon Corp Sells 285,307 Shares of Summit Hotel Properties, Inc. $INN

Cetera Investment Advisers Acquires Shares of 27,935 Pinnacle Financial Partners, Inc. $PNFP

Strip Tinning Wins £3m DRIVE35 Grant to Scale EV Component Production

Innoviz Technologies Ltd (INVZ) Earnings Forecast: Future EPS & Revenue Growth Estimates

Nitin Spinners Q1FY27 net profit jumps 84% as margins expand

European Innovation Solutions S.A. Revenue Breakdown – ATHEX:EIS

Innovex International (NYSE:INVX) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded Innovex International (NYSE:INVX) from "hold" to "buy," contributing to a "Moderate Buy" consensus and an average price target of $32.25. The company recently reported strong quarterly earnings, beating analyst estimates for both EPS and revenue. Institutional investors have increased their …

ETFs Investing in Guangzhou Innogen Pharmaceutical Group Co Ltd Class H Stocks

Onto Innovation (NYSE:ONTO) Releases Earnings Results, Beats Expectations By $0.24 EPS

Summit Hotel Properties (INN) Stock Price Slips As Guidance Rises

Summit Hotel Properties (INN) saw its stock price slip despite reporting a return to profitability in Q2 2026 and raising its full-year guidance for adjusted funds from operations and revenue per available room. The company's RevPAR increased by 5%, driven by a 7.1% rise …

PNW6075358 Bond Profile — Key Metrics

This article provides a detailed profile of the PNW6075358 bond issued by Pinnacle West Capital Corporation. It outlines key metrics such as the 5.15% coupon rate, May 15, 2030 maturity date, and a $400 million outstanding amount. The article also describes Pinnacle West Capital …

Onto Innovation Q2 Earnings Call Highlights

Key Points Interested in Onto Innovation Inc.? Here are five stocks we like better. Strong second-quarter performance: Revenue rose 35% year over year to $343 million, while non-GAAP EPS of $1.93 exceeded the high end of guidance. Gross margin reached 57% and operating margin …

Innovate Stock Soars Over 42% Overnight: Here's What You Need to Know

Innovate Corp. (NYSE: VATE) shares surged over 42% in after-hours trading following the announcement of strong second-quarter results, with revenue growing approximately 74% and diluted EPS turning positive. The company reported significant increases in revenue and Adjusted EBITDA, primarily driven by its Infrastructure segment. …

Is Innospec (IOSP) Still Undervalued After Its Q2 Earnings Beat?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Innospec stock has climbed 21.2% year to date, yet the latest valuation work suggests the current share price may still sit below an …